サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390431

神経修復および再生市場レポート：手術別、製品別、エンドユーザー別、地域別、2023-2028年

Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
神経修復および再生市場レポート：手術別、製品別、エンドユーザー別、地域別、2023-2028年
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の神経修復および再生市場規模は2022年に77億米ドルに達しました。今後、IMARC Groupは、2022年から2028年にかけて11.51%の成長率（CAGR）を示し、2028年までに148億米ドルに達すると予測しています。

神経修復および再生（NRaR）とは、神経損傷の治療に用いられる神経組織工学プロセスを指します。新しい神経細胞、グリア細胞、ミエリン、軸索、シナプスの再生を促進します。また、通常は神経の圧迫、鈍的外傷、伸張、切断によって引き起こされる神経損傷後の神経の正常な機能の回復を助ける。NRaRには、生体材料やさまざまな神経刺激・神経調節デバイスが使用されます。生体材料には、神経導管、神経プロテクター、神経ラップ、神経コネクターなどがあります。これらは、直接神経障害、神経移植、幹細胞治療、経皮、経頭蓋磁気、脊髄、脳深部、仙骨神経、迷走神経刺激などに使用されます。

神経修復および再生市場の動向：

アルツハイマー病、パーキンソン病、筋萎縮性側索硬化症、多発性硬化症、多系統萎縮症などの慢性神経疾患の有病率の増加は、市場成長を促進する主な要因の一つです。さらに、このような病気にかかりやすい老年人口の増加や神経損傷の事例の増加が、市場の成長を後押ししています。世界中のヘルスケア、外来手術センター（ASCs）、その他の医療機関は、神経障害のタイムリーな診断と治療のために新しいNRaRソリューションを提供しています。加えて、幹細胞治療における様々な技術の進歩や、革新的な神経調節装置の開発が、他の成長促進要因として作用しています。内因性幹細胞は、中枢神経系の損傷組織の効果的な修復や置換のために、神経新生、神経修復、外因性神経幹細胞移植に広く利用されています。特に新興経済諸国では、医療インフラの大幅な改善とともに、大衆の医療費の増加など、その他の要因も市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 2022年の神経修復および再生の世界市場規模は？
  • 2023～2028年の世界の神経修復および再生市場の予想成長率は？
  • 世界の神経修復および再生市場を牽引する主要因は何か？
  • COVID-19が世界の神経修復および再生市場に与えた影響は？
  • 世界の神経修復および再生市場の手術別区分は？
  • 神経修復および再生の世界市場の製品別区分は？
  • 神経修復および再生の世界市場のエンドユーザー別区分は？
  • 神経修復および再生の世界市場における主要地域は？
  • 神経修復および再生の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の神経修復および再生市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：手術別

  • 直接神経修復術／神経切除術
    • 市場動向
    • 市場予測
  • 神経移植術
    • 市場動向
    • 市場予測
  • 幹細胞治療
    • 市場動向
    • 市場予測
  • 神経刺激と神経調節手術
    • 市場動向
    • 市場予測

第7章 市場内訳：製品別

  • バイオマテリアル
    • 市場動向
    • 市場予測
  • 神経刺激および神経調節デバイス
    • 市場動向
    • 主要セグメント
      • 脊髄刺激デバイス
      • 脳深部刺激装置
      • 仙骨神経刺激装置
      • 迷走神経刺激装置
      • 胃電気刺激装置
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Alafair Biosciences Inc.
    • AxoGen Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Collagen Matrix Inc.
    • Integra Lifesciences Corporation
    • Medtronic plc
    • Polyganics BV
    • Soterix Medical Inc.
    • Stryker Corporation
    • Synapse Biomedical Inc.
図表

List of Figures

  • Figure 1: Global: Nerve Repair and Regeneration Market: Major Drivers and Challenges
  • Figure 2: Global: Nerve Repair and Regeneration Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Nerve Repair and Regeneration Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Nerve Repair and Regeneration Market: Breakup by Surgery (in %), 2022
  • Figure 5: Global: Nerve Repair and Regeneration Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Nerve Repair and Regeneration Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Nerve Repair and Regeneration Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Nerve Repair and Regeneration (Nerve Grafting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Nerve Repair and Regeneration (Nerve Grafting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Nerve Repair and Regeneration (Biomaterial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Nerve Repair and Regeneration (Biomaterial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Nerve Repair and Regeneration Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Nerve Repair and Regeneration Industry: SWOT Analysis
  • Figure 74: Global: Nerve Repair and Regeneration Industry: Value Chain Analysis
  • Figure 75: Global: Nerve Repair and Regeneration Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nerve Repair and Regeneration Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Surgery (in Million US$), 2023-2028
  • Table 3: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Nerve Repair and Regeneration Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Nerve Repair and Regeneration Market: Competitive Structure
  • Table 7: Global: Nerve Repair and Regeneration Market: Key Players
目次
Product Code: SR112023A4159

Abstract

The global nerve repair and regeneration market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.51% during 2022-2028.

Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.

Nerve Repair and Regeneration Market Trends:

The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nerve repair and regeneration market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on surgery, product and end user.

Breakup by Surgery:

Direct Nerve Repair/Neurorrhaphy

Nerve Grafting

Stem Cell Therapy

Neurostimulation and Neuromodulation Surgeries

Breakup by Product:

Biomaterial

Neurostimulation and Neuromodulation Devices

Spinal Cord Stimulation Devices

Deep Brain Stimulation Devices

Sacral Nerve Stimulation Devices

Vagus Nerve Stimulation Devices

Gastric Electric Stimulation Devices

Breakup by End User:

Hospitals and Clinics

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alafair Biosciences Inc., AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Collagen Matrix Inc., Integra Lifesciences Corporation, Medtronic plc, Polyganics BV, Soterix Medical Inc., Stryker Corporation and Synapse Biomedical Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global nerve repair and regeneration market in 2022?
  • 2. What is the expected growth rate of the global nerve repair and regeneration market during 2023-2028?
  • 3. What are the key factors driving the global nerve repair and regeneration market?
  • 4. What has been the impact of COVID-19 on the global nerve repair and regeneration market?
  • 5. What is the breakup of the global nerve repair and regeneration market based on the surgery?
  • 6. What is the breakup of the global nerve repair and regeneration market based on the product?
  • 7. What is the breakup of the global nerve repair and regeneration market based on the end user?
  • 8. What are the key regions in the global nerve repair and regeneration market?
  • 9. Who are the key players/companies in the global nerve repair and regeneration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nerve Repair and Regeneration Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Surgery

  • 6.1 Direct Nerve Repair/Neurorrhaphy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Nerve Grafting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Stem Cell Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Neurostimulation and Neuromodulation Surgeries
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurostimulation and Neuromodulation Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Spinal Cord Stimulation Devices
      • 7.2.2.2 Deep Brain Stimulation Devices
      • 7.2.2.3 Sacral Nerve Stimulation Devices
      • 7.2.2.4 Vagus Nerve Stimulation Devices
      • 7.2.2.5 Gastric Electric Stimulation Devices
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alafair Biosciences Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AxoGen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Collagen Matrix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Integra Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Polyganics BV
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Soterix Medical Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Synapse Biomedical Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio